James L Gulley Selected Research

Panvac-VF

4/2007

PANVAC-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James L Gulley Research Topics

Disease

169	Neoplasms (Cancer) 04/2022 - 01/2003
133	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 01/2003
27	Carcinoma (Carcinomatosis) 01/2022 - 02/2005
25	Disease Progression 01/2022 - 05/2004
19	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2004
17	Vaccinia 01/2020 - 02/2005
13	Fowlpox 01/2018 - 02/2005
10	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2006
8	Melanoma (Melanoma, Malignant) 03/2022 - 12/2010
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 01/2013
6	Chordoma 01/2021 - 11/2015
5	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 10/2015
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 10/2013
5	Fatigue 01/2021 - 06/2013
4	COVID-19 01/2021 - 01/2020
4	Merkel Cell Carcinoma 01/2020 - 01/2017
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2016
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 06/2009
3	Human Influenza (Influenza) 01/2021 - 02/2014
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2019 - 01/2017
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2020
2	Inflammation (Inflammations) 01/2022 - 09/2020
2	Pneumonia (Pneumonitis) 01/2021 - 01/2018
2	Urogenital Neoplasms 01/2021 - 01/2020
2	Infections 01/2021 - 01/2021
2	Circulating Neoplastic Cells 01/2021 - 01/2017
2	Edema (Dropsy) 01/2020 - 11/2015

Drug/Important Bio-Agent (IBA)

93	VaccinesIBA 11/2022 - 08/2003
39	AntigensIBA 01/2021 - 08/2003
36	Immune Checkpoint InhibitorsIBA 03/2022 - 08/2011
35	Cancer VaccinesIBA 01/2022 - 05/2005
31	AndrogensIBA 01/2022 - 01/2003
30	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 08/2003
29	PROSTVACIBA 01/2021 - 07/2009
27	avelumabIBA 11/2022 - 10/2015
21	sipuleucel-T (APC8015)FDA Link 01/2020 - 01/2010
20	Docetaxel (Taxotere)FDA Link 01/2021 - 01/2003
17	IpilimumabIBA 11/2020 - 02/2007
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2007
12	Monoclonal AntibodiesIBA 03/2022 - 02/2007
12	B7-H1 AntigenIBA 01/2022 - 07/2017
10	Brachyury protein (Brachyury)IBA 01/2021 - 10/2015
9	Immunoglobulin G (IgG)IBA 12/2020 - 01/2011
9	Carcinoembryonic AntigenIBA 11/2015 - 08/2003
8	NivolumabIBA 01/2022 - 12/2014
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2004
8	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 02/2005
8	LigandsIBA 12/2020 - 10/2012
8	PlatinumIBA 10/2020 - 01/2017
8	Thalidomide (Thalomid)FDA Link 04/2010 - 01/2003
7	Prednisone (Sone)FDA LinkGeneric 01/2021 - 02/2009
7	CytokinesIBA 01/2021 - 02/2009
7	Hormones (Hormone)IBA 03/2009 - 07/2005
6	Testosterone (Sustanon)FDA Link 04/2022 - 05/2004
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2006
6	Peptides (Polypeptides)IBA 08/2016 - 08/2003
6	EpitopesIBA 01/2013 - 08/2003
6	VA 061 (VA061)IBA 01/2008 - 01/2003
5	pembrolizumabIBA 01/2022 - 01/2017
5	enzalutamideIBA 01/2022 - 01/2020
5	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 10/2007
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2015
5	AntibodiesIBA 10/2020 - 01/2019
4	Bevacizumab (Avastin)FDA Link 11/2022 - 02/2009
4	Interleukin-12 (IL 12)IBA 01/2022 - 10/2015
4	SteroidsIBA 01/2021 - 12/2018
4	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 03/2010
4	Biological ProductsIBA 01/2019 - 07/2013
3	AutoantigensIBA 01/2022 - 01/2006
3	FluoridesIBA 01/2022 - 11/2018
3	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2018
3	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 01/2021 - 08/2019
3	cabozantinibIBA 01/2021 - 01/2020
3	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2020 - 01/2019
3	Androgen Antagonists (Antiandrogens)IBA 01/2019 - 03/2005
3	Lenalidomide (CC 5013)FDA Link 10/2016 - 03/2004
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2015 - 02/2005
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2013 - 05/2005
3	Diphosphonates (Bisphosphonates)IBA 02/2009 - 01/2007
2	Sunitinib (Sutent)FDA Link 01/2022 - 10/2013
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 08/2016
2	Interleukin-15 (Interleukin 15)IBA 01/2022 - 09/2017
2	Therapeutic UsesIBA 01/2022 - 01/2018
2	CalciumIBA 01/2022 - 09/2007
2	Axitinib (AG 013736)IBA 01/2022 - 01/2020
2	olaparibIBA 12/2021 - 12/2018
2	durvalumabIBA 12/2021 - 12/2018
2	Methylprednisolone FDA LinkGeneric 11/2020 - 12/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2020 - 01/2020
2	prostatic acid phosphataseIBA 01/2020 - 01/2017
2	Radium-223IBA 12/2019 - 01/2016

Therapy/Procedure

99	Therapeutics 01/2022 - 05/2003
77	Immunotherapy 11/2022 - 01/2006
48	Castration 01/2022 - 04/2004
27	Drug Therapy (Chemotherapy) 01/2021 - 02/2006
17	Radiotherapy 01/2021 - 05/2003
4	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2019
4	Aftercare (After-Treatment) 01/2022 - 01/2020
3	Intravenous Infusions 10/2019 - 01/2018
2	Duration of Therapy 11/2020 - 01/2019